Role of Kankasav in the management of spo2 level of covid 19 patients
Phase 3
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/05/033695
- Lead Sponsor
- DrPrasad Kulkarni
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Subjects with positive rapid antigen test OR RT-PCR â?? reverse transcription polymerase chain reaction with blood oxygen saturation (SpO2) >= 85 up to 94HRCT score >=7 or above
Subjects having at least any one of the diagnostic criteria.
Patient between age group 20-70 years of age.
Patients of any gender, and willing for trial.
Irrespective of socioeconomic condition of patient.
Exclusion Criteria
1) Subjects having critical illness.
2) subjects having SPo2 below 85.
3) Subjects not willing for trial.
4) Pregnant females and lactating mothers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SPo2 level of patients are increased and dyspnoea reducedTimepoint: 2 to 3 weeks
- Secondary Outcome Measures
Name Time Method Changes in pulse rate,respiratory rate,Timepoint: 2 to 3 weeks